Search Medical Condition
Please enter condition
Please choose location from dropdown

Pharyngitis Clinical Trials

A listing of Pharyngitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (433) clinical trials

The relatively restricted C4.4a expression pattern provides a target for the selective delivery of a cytotoxic drug to C4.4.a-expressing tumor cells by means of a suitable antibody-drug conjugate. The subject population eligible for the current study will be those subjects with advanced malignancies known to express C4.4a, which are refractory ...

Phase

People with oral mucositis and head and neck cancer are asked to participate in a research study being conducted by Northwell Health.  

People with oral mucositis and head and neck cancer are asked to participate in a research study being conducted by Northwell Health.

Phase N/A

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis

During the course of ALS most patients develop swallowing deficits. In this pilot study we investigate if dysphagia in ALS can be improved by Pharyngeal Electrical Stimulation (PES). PES is Communaut Europenne (CE-) certificated and has been approved for treatment of neurological, oropharyngeal dysphagia. During PES, electrical stimuli are applied ...

Phase

Immune Disorder HSCT Protocol

This study hypothesizes that a reduced intensity immunosuppressive preparative regimen will establish engraftment of donor hematopoietic cells with acceptable early and delayed toxicity in patients with immune function disorders. A regimen that maximizes host immune suppression is expected to reduce graft rejection and optimize donor cell engraftment.

Phase

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

The SYNERGY Registry is an international prospective, observational cohort study of eligible adult and pediatric pts with advanced solid and hematological malignancies, for whom the decision to consider CTE has already been made by their primary providers (PP). Using a proprietary application programming interface (API) linked to existing electronic health ...

Phase N/A

Study Comparing Pembrolizumab With Methotrexate in Elderly Frail or Cisplatin-ineligible Patients With Head and Neck Cancers

The study is designed as an open-label, randomized, prospective, multicenter, phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with squamous carcinoma of the head and neck (HNSCC)

Phase

The Characterisation of RT Caries.

Introduction Head and neck cancer is the sixth most common cancer in the world representing 4-5% of all malignancies . Head and neck cancer (includes oral, nasal cavity, salivary glands, paranasal sinus, pharynx, and larynx) is one of the top 10 most diagnosed cancers in the UK . According to ...

Phase N/A

Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

Further information is provided in van Schalkwyk MC, Papa SE, Jeannon JP, Guerrero Urbano T, Spicer JF, Maher J. Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer. Hum Gene Ther Clin Dev. ...

Phase

Observational Study on Biomarkers in Head and Neck Cancer (HNpr dBio)

Objectives Primary: Evaluation of local-regional recurrence- free survival after two years of patients with locally advanced head and neck cancer who received definitive or adjuvant radiochemotherapy. Secondary: Evaluation of disease-free -survival, metastases-free and overall survival after two years, of patients with locally advanced head and neck cancer. Outline: This is ...

Phase N/A